Literature DB >> 12639711

Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins.

Dieter Rosskopf1, Karin Koch, Christiane Habich, Jörg Geerdes, Axel Ludwig, Sabine Wilhelms, Karl H Jakobs, Winfried Siffert.   

Abstract

The T-allele of a polymorphism (C825T) in the gene of the G-protein beta3-subunit is associated with a complex phenotype (hypertension, obesity, altered drug responses) and the occurrence of a splice variant termed Gbeta3s which lacks one of the seven WD-domains that compose Gbeta-proteins. Here, we analysed Gbetagamma dimer formation and Galpha activation by Gbeta3s, key functional characteristics of Gbeta-proteins. Cleavage protection assays frequently used to analyse Gbeta1gamma and Gbeta2gamma dimer formation failed for Gbeta3 and Gbeta3s, while in coprecipitation assays, dimerization of Gbeta3 and Gbeta3s with Ggamma5, Ggamma8(c) and Ggamma12 could be demonstrated. Upon expression of Gbeta3s in COS-7 and Sf9 insect cells, binding of GTPgammaS to Galpha-proteins induced by mastoparan-7 and the M(2) muscarinic acetylcholine receptor was facilitated in comparison with cells overexpressing wildtype Gbeta3, as indicated by twofold reduced agonist EC(50) values. Together, these results indicate that Gbeta3s is a biologically active Gbeta-protein that may mediate the enhanced signal transduction observed in cells with the 825T-allele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639711     DOI: 10.1016/s0898-6568(02)00140-7

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

Review 1.  Structural determinants involved in the formation and activation of G protein betagamma dimers.

Authors:  William E McIntire
Journal:  Neurosignals       Date:  2009-02-12

Review 2.  Gene variants predisposing to SIDS: current knowledge.

Authors:  Siri H Opdal; Torleiv O Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-11       Impact factor: 2.007

3.  Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression.

Authors:  S Anttila; K Huuhka; M Huuhka; R Rontu; K M Mattila; E Leinonen; T Lehtimäki
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

4.  Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.

Authors:  Andreas Eisenhardt; Winfried Siffert; Dieter Rosskopf; Michael Musch; Max Mosters; Ulla Roggenbuck; Karl-Heinz Jöckel; Herbert Rübben; Gerd Lümmen
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

Review 5.  Genetics of cluster headache.

Authors:  Markus Schürks
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 6.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

7.  Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia.

Authors:  Yuanchao Ye; Zhizeng Sun; Ang Guo; Long-Sheng Song; Justin L Grobe; Songhai Chen
Journal:  Cell Signal       Date:  2014-08-02       Impact factor: 4.315

8.  Prenylation-deficient G protein gamma subunits disrupt GPCR signaling in the zebrafish.

Authors:  Timothy Mulligan; Heiko Blaser; Erez Raz; Steven A Farber
Journal:  Cell Signal       Date:  2009-09-26       Impact factor: 4.315

9.  Pharmacogenetics of low dose clonidine in irritable bowel syndrome.

Authors:  M Camilleri; I Busciglio; P Carlson; S McKinzie; D Burton; K Baxter; M Ryks; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2009-04       Impact factor: 3.598

10.  The Gβ3 splice variant associated with the C825T gene polymorphism is an unstable and functionally inactive protein.

Authors:  Zhizeng Sun; Caitlin Runne; Xiaoyun Tang; Fang Lin; Songhai Chen
Journal:  Cell Signal       Date:  2012-08-30       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.